MSNCs and MgO-MSNCs as drug delivery systems to control the adsorption kinetics and release rate of indometacin. [PDF]
Zheng X +6 more
europepmc +1 more source
Modelling stem cell differentiation related processes—A practical overview for biologists
Stem cell differentiation is complex and difficult to control experimentally. This review introduces suitable computational modelling approaches that can support stem cell research, from mechanistic ODE and abstract models to multiscale and deep learning methods.
Ricco Zeegelaar +4 more
wiley +1 more source
Enhanced Control of Nonlinear Systems Under Control Input Constraints and Faults: A Neural Network-Based Integral Fuzzy Sliding Mode Approach. [PDF]
Yang G +5 more
europepmc +1 more source
A Functional Subnetwork Approach to Designing Synthetic Nervous Systems That Control Legged Robot Locomotion. [PDF]
Szczecinski NS, Hunt AJ, Quinn RD.
europepmc +1 more source
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens +8 more
wiley +1 more source
Fentanyl activates opposing opioid and non-opioid receptor systems that control breathing. [PDF]
Baby SM +7 more
europepmc +1 more source
Chemosensory signaling systems that control bacterial survival. [PDF]
He K, Bauer CE.
europepmc +1 more source
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani +3 more
wiley +1 more source
Koopman Invariant Subspaces and Finite Linear Representations of Nonlinear Dynamical Systems for Control. [PDF]
Brunton SL +3 more
europepmc +1 more source
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi +6 more
wiley +1 more source

